Viewing Study NCT00058292


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-03-09 @ 2:57 PM
Study NCT ID: NCT00058292
Status: COMPLETED
Last Update Posted: 2012-06-01
First Post: 2003-04-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor: Northwestern University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult Burkitt lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent mantle cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View